本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Madrigal Pharmaceuticals, Inc.

477.34
-3.6600-0.76%
成交量:8.63萬
成交額:4,105.70萬
市值:108.41億
市盈率:-36.62
高:484.00
開:483.90
低:468.08
收:481.00
52周最高:615.00
52周最低:265.00
股本:2,271.14萬
流通股本:1,100.01萬
量比:0.27
換手率:0.78%
股息:- -
股息率:- -
每股收益(TTM):-13.0355
每股收益(LYR):-21.9007
淨資產收益率:-41.22%
總資產收益率:-15.78%
市淨率:17.33
市盈率(LYR):-21.80

資料載入中...

2026/01/30

重要事件披露

Form 8-K - Current report
2026/01/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/11

重要事件披露

Form 8-K - Current report
2025/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/04

重要事件披露

Form 8-K - Current report
2025/09/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans